Inficiálódott nekrotizáló pancreatitis komplex kezelése.

Translated title of the contribution: Complex treatment of infected necrotizing pancreatitis

G. Farkas, J. Márton, Y. Mándi, E. Nagy, E. Szederkényi

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Pancreatic necrosis associated with septic conditions is the leading cause of mortality in acute pancreatitis. Since 1986, 155 patients with infected pancreatic necrosis have been treated. The mean APACHE II score was 18.5 (range 11-32). In all cases, the infected pancreatic necrosis was combined with retroperitoneal abscesses. The surgical treatment was performed on average 18.5 days (range 8-25 days) after the onset of acute pancreatitis. The operative management consisted of wide-ranging necrosectomy in the total affected area, combined with widespread lavage and suction drainage. In 69 of the 155 cases (45%), some other surgical intervention (distal pancreatic resection, splenectomy, cholecystectomy, sphincteroplasty or colon resection) was also performed. Following surgery supportive therapy was applied in all patients, which also consisted orf immunonutrition (glutamine and arginine supplementation) and modification of cytokine production by petoxyfillin and dexamethasone from 1992. TNF and IL-6 serum levels were measured by ELISA and in vitro stimulation of leukocytes were induced by E. coli LPS. Following surgery, continuous lavage and suction drainage were applied for an average of 41.5 days (range 21-90 days), with an average of 9.5 (range 5-20) litres of saline per day. The bacteriologic findings revealed mainly enteral bacteria, but Candida infection was also frequently detected. The incidence of fungal infection was 20%. Thirty-two patients (21%) had to undergo reoperation. The cytokine production capacity (TNF and IL-6) was shown to correlate with the prognosis. As a consequence of pentoxifyllin and dexamethasone therapy, the TNF production generally dropped to the normal level. The overall hospital mortality was 6.4% (10 patients died). In our experience, infected pancreatic necrosis responds well to aggressive surgical treatment, continuous, long-standing lavage and suction drainage, together with supportive therapy consisting of immunonutrition and modification of cytokine production, combined with adequate antibiotic and antifungal medication.

Original languageHungarian
Pages (from-to)2235-2240
Number of pages6
JournalOrvosi Hetilap
Volume139
Issue number38
Publication statusPublished - Sep 20 1998

Fingerprint

Pancreatitis
Therapeutic Irrigation
Suction
Necrosis
Cytokines
Dexamethasone
Interleukin-6
Contagious Ecthyma
Therapeutics
APACHE
Mycoses
Antifungal Agents
Cholecystectomy
Splenectomy
Hospital Mortality
Glutamine
Reoperation
Candida
Abscess
Small Intestine

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Farkas, G., Márton, J., Mándi, Y., Nagy, E., & Szederkényi, E. (1998). Inficiálódott nekrotizáló pancreatitis komplex kezelése. Orvosi Hetilap, 139(38), 2235-2240.

Inficiálódott nekrotizáló pancreatitis komplex kezelése. / Farkas, G.; Márton, J.; Mándi, Y.; Nagy, E.; Szederkényi, E.

In: Orvosi Hetilap, Vol. 139, No. 38, 20.09.1998, p. 2235-2240.

Research output: Contribution to journalArticle

Farkas, G, Márton, J, Mándi, Y, Nagy, E & Szederkényi, E 1998, 'Inficiálódott nekrotizáló pancreatitis komplex kezelése.', Orvosi Hetilap, vol. 139, no. 38, pp. 2235-2240.
Farkas G, Márton J, Mándi Y, Nagy E, Szederkényi E. Inficiálódott nekrotizáló pancreatitis komplex kezelése. Orvosi Hetilap. 1998 Sep 20;139(38):2235-2240.
Farkas, G. ; Márton, J. ; Mándi, Y. ; Nagy, E. ; Szederkényi, E. / Inficiálódott nekrotizáló pancreatitis komplex kezelése. In: Orvosi Hetilap. 1998 ; Vol. 139, No. 38. pp. 2235-2240.
@article{d6fb9bf3cbb047f1bc04497019f570e8,
title = "Infici{\'a}l{\'o}dott nekrotiz{\'a}l{\'o} pancreatitis komplex kezel{\'e}se.",
abstract = "Pancreatic necrosis associated with septic conditions is the leading cause of mortality in acute pancreatitis. Since 1986, 155 patients with infected pancreatic necrosis have been treated. The mean APACHE II score was 18.5 (range 11-32). In all cases, the infected pancreatic necrosis was combined with retroperitoneal abscesses. The surgical treatment was performed on average 18.5 days (range 8-25 days) after the onset of acute pancreatitis. The operative management consisted of wide-ranging necrosectomy in the total affected area, combined with widespread lavage and suction drainage. In 69 of the 155 cases (45{\%}), some other surgical intervention (distal pancreatic resection, splenectomy, cholecystectomy, sphincteroplasty or colon resection) was also performed. Following surgery supportive therapy was applied in all patients, which also consisted orf immunonutrition (glutamine and arginine supplementation) and modification of cytokine production by petoxyfillin and dexamethasone from 1992. TNF and IL-6 serum levels were measured by ELISA and in vitro stimulation of leukocytes were induced by E. coli LPS. Following surgery, continuous lavage and suction drainage were applied for an average of 41.5 days (range 21-90 days), with an average of 9.5 (range 5-20) litres of saline per day. The bacteriologic findings revealed mainly enteral bacteria, but Candida infection was also frequently detected. The incidence of fungal infection was 20{\%}. Thirty-two patients (21{\%}) had to undergo reoperation. The cytokine production capacity (TNF and IL-6) was shown to correlate with the prognosis. As a consequence of pentoxifyllin and dexamethasone therapy, the TNF production generally dropped to the normal level. The overall hospital mortality was 6.4{\%} (10 patients died). In our experience, infected pancreatic necrosis responds well to aggressive surgical treatment, continuous, long-standing lavage and suction drainage, together with supportive therapy consisting of immunonutrition and modification of cytokine production, combined with adequate antibiotic and antifungal medication.",
author = "G. Farkas and J. M{\'a}rton and Y. M{\'a}ndi and E. Nagy and E. Szederk{\'e}nyi",
year = "1998",
month = "9",
day = "20",
language = "Hungarian",
volume = "139",
pages = "2235--2240",
journal = "Orvosi Hetilap",
issn = "0030-6002",
publisher = "Akademiai Kiado",
number = "38",

}

TY - JOUR

T1 - Inficiálódott nekrotizáló pancreatitis komplex kezelése.

AU - Farkas, G.

AU - Márton, J.

AU - Mándi, Y.

AU - Nagy, E.

AU - Szederkényi, E.

PY - 1998/9/20

Y1 - 1998/9/20

N2 - Pancreatic necrosis associated with septic conditions is the leading cause of mortality in acute pancreatitis. Since 1986, 155 patients with infected pancreatic necrosis have been treated. The mean APACHE II score was 18.5 (range 11-32). In all cases, the infected pancreatic necrosis was combined with retroperitoneal abscesses. The surgical treatment was performed on average 18.5 days (range 8-25 days) after the onset of acute pancreatitis. The operative management consisted of wide-ranging necrosectomy in the total affected area, combined with widespread lavage and suction drainage. In 69 of the 155 cases (45%), some other surgical intervention (distal pancreatic resection, splenectomy, cholecystectomy, sphincteroplasty or colon resection) was also performed. Following surgery supportive therapy was applied in all patients, which also consisted orf immunonutrition (glutamine and arginine supplementation) and modification of cytokine production by petoxyfillin and dexamethasone from 1992. TNF and IL-6 serum levels were measured by ELISA and in vitro stimulation of leukocytes were induced by E. coli LPS. Following surgery, continuous lavage and suction drainage were applied for an average of 41.5 days (range 21-90 days), with an average of 9.5 (range 5-20) litres of saline per day. The bacteriologic findings revealed mainly enteral bacteria, but Candida infection was also frequently detected. The incidence of fungal infection was 20%. Thirty-two patients (21%) had to undergo reoperation. The cytokine production capacity (TNF and IL-6) was shown to correlate with the prognosis. As a consequence of pentoxifyllin and dexamethasone therapy, the TNF production generally dropped to the normal level. The overall hospital mortality was 6.4% (10 patients died). In our experience, infected pancreatic necrosis responds well to aggressive surgical treatment, continuous, long-standing lavage and suction drainage, together with supportive therapy consisting of immunonutrition and modification of cytokine production, combined with adequate antibiotic and antifungal medication.

AB - Pancreatic necrosis associated with septic conditions is the leading cause of mortality in acute pancreatitis. Since 1986, 155 patients with infected pancreatic necrosis have been treated. The mean APACHE II score was 18.5 (range 11-32). In all cases, the infected pancreatic necrosis was combined with retroperitoneal abscesses. The surgical treatment was performed on average 18.5 days (range 8-25 days) after the onset of acute pancreatitis. The operative management consisted of wide-ranging necrosectomy in the total affected area, combined with widespread lavage and suction drainage. In 69 of the 155 cases (45%), some other surgical intervention (distal pancreatic resection, splenectomy, cholecystectomy, sphincteroplasty or colon resection) was also performed. Following surgery supportive therapy was applied in all patients, which also consisted orf immunonutrition (glutamine and arginine supplementation) and modification of cytokine production by petoxyfillin and dexamethasone from 1992. TNF and IL-6 serum levels were measured by ELISA and in vitro stimulation of leukocytes were induced by E. coli LPS. Following surgery, continuous lavage and suction drainage were applied for an average of 41.5 days (range 21-90 days), with an average of 9.5 (range 5-20) litres of saline per day. The bacteriologic findings revealed mainly enteral bacteria, but Candida infection was also frequently detected. The incidence of fungal infection was 20%. Thirty-two patients (21%) had to undergo reoperation. The cytokine production capacity (TNF and IL-6) was shown to correlate with the prognosis. As a consequence of pentoxifyllin and dexamethasone therapy, the TNF production generally dropped to the normal level. The overall hospital mortality was 6.4% (10 patients died). In our experience, infected pancreatic necrosis responds well to aggressive surgical treatment, continuous, long-standing lavage and suction drainage, together with supportive therapy consisting of immunonutrition and modification of cytokine production, combined with adequate antibiotic and antifungal medication.

UR - http://www.scopus.com/inward/record.url?scp=0032552315&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032552315&partnerID=8YFLogxK

M3 - Article

VL - 139

SP - 2235

EP - 2240

JO - Orvosi Hetilap

JF - Orvosi Hetilap

SN - 0030-6002

IS - 38

ER -